Health24.com | Meet the skinny pig that makes low fat bacon

02 September 2019

Meet the skinny pig that makes low fat bacon

Scientists have discovered a way to make the piggies that go to market skinnier but will this new, low-fat bacon ever reach your table?

Good news for people on low-fat diets and bacon lovers. Scientists have shown that there is now a way farmers can produce low-fat bacon and cut costs at the same time. 

Image credit: iStock

NEXT ON HEALTH24X

Live healthier

Share Button

Police ‘dealing with more mental health incidents’

The number of cases dealt with by police has risen by more than a quarter in four years, figures suggest.

Share Button

Health24.com | WATCH: People are paying big money to cuddle with cows

A cow cuddling craze has hit the US and is quickly spreading to other parts of the world. The supposed stress-relieving wellness experience allows for a cow-cuddle for up to 90 minutes. It also apparently has health benefits, including lowering your anxiety and heart rate. But if you need to unplug and de-stress, it’s going to cost you a weighty fee…

Image: iStock

Share Button

Call for HPV jab to be offered to older boys

The Teenage Cancer Trust says boys and young men who want to have the HPV jab should not have to pay.

Share Button

For patients with diabetes, ticagrelor reduced heart attacks, strokes

In late-breaking clinical trial results presented in a Hot Line Session today at the European Society of Cardiology Congress 2019, investigators from Brigham and Women’s Hospital and Greater Paris University Hospitals — AP-HP/Université de Paris presented the results from The Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study (THEMIS), a clinical trial sponsored by AstraZeneca that evaluated whether adding ticagrelor to aspirin improves outcomes for patients with stable coronary artery disease and diabetes mellitus but without a history of heart attack or stroke. Taking ticagrelor in addition to aspirin reduced the risk of a composite of cardiovascular death, heart attack, or stroke. Patients on this dual-antiplatelet therapy also experienced greater risk of major bleeding. In THEMIS-PCI, a study that specifically looked at THEMIS patients with a history of previous percutaneous coronary intervention (PCI) that includes stenting, versus the overall THEMIS population, investigators found even more favorable results for patients taking ticagrelor plus aspirin. Results of THEMIS are published simultaneously in The New England Journal of Medicine and results from THEMIS-PCI are published simultaneously in The Lancet.

“With prolonged dual-antiplatelet therapy, we need to be thoughtful in considering which patients are most suited to taking the regimen — that is, those at high ischemic risk and low bleeding risk,” said THEMIS co-chair Deepak L. Bhatt, MD, MPH, executive director of Interventional Cardiovascular Programs at the Brigham and professor of medicine at Harvard Medical School. “Our findings show that the greatest benefit occurred in those patients with diabetes and stable coronary artery disease with a history of prior stenting for whom ticagrelor, when added to aspirin, reduced important cardiovascular events, such as heart attacks, strokes and amputations.”

THEMIS co-chair Philippe Gabriel Steg, MD, Chief of Cardiology at Hôpital Bichat, Greater Paris University Hospitals — AP-HP, and professor at Université de Paris, stated, “The THEMIS population is a critically important one in which to understand the potential benefits of taking ticagrelor in addition to aspirin. As the number of people with diabetes continues to rise globally, we need to evaluate ways of improving long-term outcomes and preventing cardiovascular and ischemic events.”

In THEMIS, the largest trial of patients with diabetes to date, more than 19,000 patients with stable coronary artery disease and diabetes were randomized to receive either ticagrelor plus aspirin or a placebo plus aspirin. Patients were followed for an average of more than three years. During that time, 736 of 9,619 patients (7.7 percent) taking ticagrelor plus aspirin experienced cardiovascular death, myocardial infarction, or stroke versus 818 of 9,601 patients (8.5 percent) taking placebo plus aspirin — a 10 percent reduction.

As seen with other anti-platelet medications, ticagrelor increased the risk of major bleeding (206 patients versus 100 patients) and intracranial hemorrhage (70 patients versus 46 patients) compared with placebo. The difference in intracranial hemorrhages was driven by an increased number of traumatic bleeds, most of them subdural, and not by spontaneous or procedural bleeding.

Among participants with a history of previous PCI, the risk reductions outweighed the increased bleeding risks. Patients who had received PCI, which commonly uses devices known as stents to widen a coronary blood vessel and keep blood flowing, accounted for the majority (58 percent) of the total THEMIS population. Among these patients in THEMIS-PCI, 404 of 5,558 (7.3 percent) participants taking ticagrelor plus aspirin experienced cardiovascular death, myocardial infarction, or stroke, versus 480 of 5,596 (8.6 percent) participants taking placebo plus aspirin — a 15 percent reduction. Major bleeding occurred in 111 of 5,536 (2.0 percent) patients receiving ticagrelor and 62 of 5,564 (1.1 percent) patients receiving placebo. The risk for intracranial bleeding was similar between ticagrelor and placebo (33 patients versus 31 patients, respectively). Ticagrelor provided a very favorable balance of benefit versus risk — more than in patients without a history of PCI.

“Our results indicate that among those with diabetes and stable coronary artery disease, we should focus on ticagrelor for patients with a history of prior stenting. This is an easily identifiable, logical sub-group,” said Bhatt. “Studies currently support using long-term dual antiplatelet therapy for patients with acute coronary syndrome who are at high ischemic risk but low bleeding risk. Our work suggests that a much broader population of patients with stable coronary artery disease and diabetes stand to benefit substantially.”

Story Source:

Materials provided by Brigham and Women’s Hospital. Note: Content may be edited for style and length.

Share Button

Flu vaccination linked with lower risk of early death in patients with high blood pressure

Influenza vaccination in patients with high blood pressure is associated with an 18% reduced risk of death during flu season, according to research presented today at ESC Congress 2019 together with the World Congress of Cardiology.

“Given these results, it is my belief that all patients with high blood pressure should have an annual flu vaccination,” said first author Daniel Modin research associate of the University of Copenhagen, Denmark. “Vaccination is safe, cheap, readily available, and decreases influenza infection. On top of that, our study suggests that it could also protect against fatal heart attacks and strokes, and deaths from other causes.”

According to previous research, the stress flu infection puts on the body may trigger heart attacks and strokes. Patients with hypertension (high blood pressure) are at raised risk of heart attack and stroke. By stopping flu infection, vaccination could also protect against cardiovascular events, but until now this had not been investigated.

The study used Danish nationwide healthcare registers to identify 608,452 patients aged 18 to 100 years with hypertension during nine consecutive influenza seasons (2007 to 2016). The researchers determined how many patients had received a flu vaccine prior to each season. They then followed patients over each season and tracked how many died. In particular, they recorded death from all causes, death from any cardiovascular cause, and death from heart attack or stroke.

Finally, they analysed the association between receiving a vaccine prior to flu season and the risk of death during flu season. The analysis controlled for patient characteristics that could impact the likelihood of dying such as age, comorbidities, medications, and socioeconomic status.

After adjusting for patient differences, in a given influenza season, vaccination was associated with an 18% relative reduction in the risk of dying from all causes, a 16% relative reduction in the risk of dying from any cardiovascular cause, and a 10% relative reduction in the risk of dying from heart attack or stroke.

Mr Modin said: “We show that influenza vaccination may improve cardiovascular outcomes in patients with hypertension. During the nine flu seasons we studied, vaccine coverage ranged from 26% to 36%, meaning that many patients with high blood pressure were not vaccinated. If you have high blood pressure, it would be worth discussing vaccination with your doctor.”

Regarding how flu and cardiovascular disease might be connected, Mr Modin noted that when the influenza virus infects the body it triggers a strong immune reaction and subsequent inflammation. These responses fight the infection and clear the virus from the body but may increase the risk of having a heart attack or stroke.

He said: “Heart attacks and strokes are caused by the rupture of atherosclerotic plaques in the arteries leading to the heart or the brain. After a rupture, a blood clot forms and cuts off the blood supply. It is thought that the high levels of acute inflammation induced by influenza infection reduce the stability of plaques and make them more likely to rupture.”

Story Source:

Materials provided by European Society of Cardiology. Note: Content may be edited for style and length.

Share Button

Childhood cholesterol, blood pressure, weight and smoking predict adult heart disease

The first reliable evidence of a link between major cardiovascular risk factors in children — serum cholesterol, blood pressure, body mass index (BMI), and smoking — with cardiovascular disease in adults is presented today at ESC Congress 2019 together with the World Congress of Cardiology. The study highlights the need to lay the foundations for heart health early in life.

Study author Professor Terence Dwyer of the University of Oxford, UK, said: “While previous research has found connections between smoking and BMI in childhood and adult cardiovascular disease, there was no data for blood pressure or serum cholesterol. In addition, it has not been possible to assess the contributions of BMI and smoking while taking cholesterol and blood pressure into account.”

The study used data from the International Childhood Cardiovascular Cohort (i3C) Consortium. Data was pooled on serum cholesterol, blood pressure, BMI, and smoking from seven child cohorts in the US, Australia, and Finland. Information was collected from 1971 onwards on approximately 40,000 children aged 3 to 19 who were followed up at around age 50 for cardiovascular events leading to hospitalisation (heart attack, stroke, peripheral arterial disease) or all-cause death.

Hazard ratios for cardiovascular events were calculated for each risk factor separately, and for all risk factors simultaneously. The latter analysis estimated how important each risk factor might be when all the others are taken into account.

For cardiovascular events leading to hospitalisation, the associations for risk factors were: 

  • BMI: 10% rise — > 20% higher risk of an event.
  • Systolic blood pressure: 10% rise — > 40% higher risk of an event.
  • Serum cholesterol: 10% rise — > 16% higher risk of an event.
  • Adolescent smoking — > 77% higher risk of an event.

In the simultaneous analysis of risk factors, the associations with future risk were reduced, suggesting a shared contribution to risk by each, although the smoking association remained relatively unchanged. The associations for death were very similar to those found for cardiovascular events.

Prof Dwyer said: “The study shows a very strong relationship between standard cardiovascular risk factors in children and the probability of a heart attack or stroke later in life. A meaningful proportion of that risk appears to be laid down in childhood and has a detrimental effect independent of adult risk factor levels. Programmes to prevent heart attacks and strokes should put more emphasis on promoting healthy lifestyles in children.”

Story Source:

Materials provided by European Society of Cardiology. Note: Content may be edited for style and length.

Share Button

Health24.com | Why ADHD might raise the risk of early death

Swedish researchers think they have honed in on why people with attention-deficit/hyperactivity disorder (ADHD) are more likely to die prematurely.

Accidental injuries, suicide and substance abuse all play a part, and psychiatric problems fuel these factors, a new study from the Karolinska Institute suggests.

Accidental injuries and suicide

To arrive at that conclusion, the researchers examined data from nearly 2.7 million people born in Sweden between 1983 and 2009. Of those, 3.2% were diagnosed with ADHD.

The risk of premature death was higher among adults with ADHD than children with ADHD, and people diagnosed with ADHD later in life had a higher risk of premature death than those diagnosed earlier in life, the findings showed.

Accidental injuries and suicide were the leading causes of death among people with ADHD, accounting for 35.8% and 31.4%, respectively, of the 414 deaths in that group.

Substance use disorders contributed substantially to the risk of death due to suicide, while the increased risk of death due to accidental injuries was evident only in those without psychiatric conditions, the study authors said in a university news release.

The investigators also found that early-onset conditions such as autism were most strongly associated with premature death due to natural causes, while later-onset psychiatric conditions, such as substance use disorders, were most strongly linked with death due to unnatural causes.

Psychiatric comorbidities

The study was published recently in the journal JAMA Psychiatry.

The findings suggest that improved awareness and care of psychiatric conditions may help reduce the risk of premature death in people with ADHD, the study authors said.

“For individuals with a diagnosis of ADHD and their family members, we need to point out that most individuals with ADHD will not suffer from these serious outcomes,” according to study senior author Henrik Larsson, a professor at Orebro University and a visiting professor at Karolinska Institute.

“The take-home message is that clinicians should consider psychiatric comorbidities carefully in their risk assessments as it may assist in identifying individuals with increased risk of premature death,” Larsson said.

Image credit: iStock

Share Button

Health24.com | New heart saved her – and it came with the name of teen who gave it

Kurt Lefteroff knew Cheryl Murdock for nine years before they started dating in September 2001. She was 42 and seemed perfectly healthy.

He didn’t know that when Murdock was in sixth grade, she was diagnosed with a heart condition. He didn’t know she had taken medications to manage that heart issue for 30 years. And he didn’t know about the episode that happened two months earlier.

A surprise trip

While on vacation, atrial fibrillation caused her heart to beat quickly and irregularly for several days. Doctors used electric shocks to restore her normal heart rhythm and recommended she follow up with her cardiologist at home in Arizona.

Lefteroff learned all this in late October, when Murdock had a second episode. She went on medication for almost a year, then received a pacemaker. Lefteroff, meanwhile, had to decide whether to continue the journey they’d begun. He did, and they became engaged in 2005. But Murdock didn’t want to get married until she felt better.

By 2009, her heart condition worsened, and her lungs were gradually failing too. Lefteroff feared Murdock may never feel strong enough to marry. So he took her on a surprise trip to the courthouse that spring to get their marriage license, telling her that it was only valid for a year.

“You can’t be waiting for a different life,” he told her. “That may never come.”

In turn, she planned a surprise wedding on his birthday, Sept. 18.

Within hours of the hospital

By 2010, Murdock developed a persistent cough. She couldn’t walk across the room without stopping to catch her breath. She was added to the heart transplant waiting list on March 26.

Because they needed to be within four hours of the hospital once a match was found, they began looking for an apartment near Stanford Medical Center in California. Four days later, Murdock’s phone rang.

Early the next morning, the heart of a 14-year-old girl was beating in Murdock’s chest.

“It was bittersweet,” Lefteroff said. “Your heart aches for the donor family’s tragedy.”

The first month, then the first three months, then the first year – these are the most critical time periods for the body not rejecting the new heart. While Murdock wanted to say the recovery was easy and she felt like a new person, that would be a lie.

During three weeks in the hospital, she vomited regularly, her weight dropping to 99 pounds. She had excruciating back pain – a combination of years working as a dental hygienist and her nearly eight-hour transplant – and could not take medications for it.

She slowly improved

The next few months in recovery were spent at their California apartment, Lefteroff monitoring her like a drill sergeant. Every morning, he checked her vital signs and wiped every surface in the apartment with bleach, ran the air purifier and tracked her medications. In the middle of every night, he changed Murdock’s sweat-soaked shirt and bed towel. He laid out her medications in shot glasses, noting the times to take each set.

She slowly improved. A few months later, they returned home to Arizona. They were allowed to write a thank-you note to the donor’s parents at seven months. They were told they had a 50-50 chance of hearing back.

They did hear back.

Murdock had been calling her heart “Tesla”, as it ran fast, ran on electricity and was expensive. But now she learned that her heart’s name was Morgan.

Morgan Gallegos was 14, a triplet who liked riding roller coasters, reading Harry Potter books and creative writing. She died from injuries sustained in a watercraft accident while on a family vacation in Mexico. Her mother worked in a hospital emergency department. Every morning, Morgan would tell her, “Save lives, Mom”. Murdock was among at least five people whose lives Morgan saved.

Murdock stayed in touch with Morgan’s parents, Margot and Tim Gallegos. In March 2018, on the eighth anniversary of her transplant, Murdock and Lefteroff met them in San Francisco. She was both excited and nervous, fearful of saying the wrong thing.

A joyful celebration

“It ended up being a very intimate connection,” she said. And Tim confided in Lefteroff that he thought meeting Murdock would help with Margot’s healing and grieving. This year, they met Morgan’s siblings, Austin and Michaela, now 23.

“Instead of being tearful this year, our meeting was more joyful, a celebration of Morgan,” Murdock said. Lefteroff said the joy has buoyed her spirits, too.

In January, Murdock celebrated her 60th birthday by going to Universal Studios and spending time at the Wizarding World of Harry Potter.

“I wrote to Morgan’s parents about what I’ve been able to do with her heart,” Murdock said. “One of those things is riding roller coasters.”

Image credit: iStock

Share Button

Sedentary lifestyle for 20 years linked to doubled early mortality risk compared to being active

Two decades of a sedentary lifestyle is associated with a two times risk of premature death compared to being physically active, according to results from the HUNT study presented today at ESC Congress 2019 together with the World Congress of Cardiology.

Study author Dr Trine Moholdt of the Norwegian University of Science and Technology, Trondheim, Norway said: “Our findings imply that to get the maximum health benefits of physical activity in terms of protection against premature all-cause and cardiovascular death, you need to continue being physically active. You can also reduce your risk by taking up physical activity later in life, even if you have not been active before.”

The aim of this study was to assess how changes in physical activity over 22 years were related to subsequent death from all causes and from cardiovascular disease. Most studies investigating the relationship between physical activity and longevity have asked participants about their level of physical activity only once, and then followed them for several years. But physical activity is a behaviour that changes in many people, so it is important to investigate how such changes over time relate to the risk of death in the future.

The HUNT study invited all residents of Norway aged 20 and older to participate in 1984-1986, 1995-1997, and 2006-2008. At all three time points, individuals were asked about their frequency and duration of leisure time physical activity. The current study used the data from the first and third surveys.

A total of 23,146 men and women were included in the analysis. Physical activity was categorised as inactive, moderate (less than two hours a week), and high (two or more hours per week). Participants were divided into groups according to their activity levels at each survey.

Physical activity data were linked to information on deaths until the end of 2013 using the Norwegian Cause of Death Registry. The risk of death in each physical activity group was compared to the reference group (those who reported a high level of exercise during both surveys). The analyses were adjusted for factors known to influence prognosis such as body mass index, age, sex, smoking, education level, and blood pressure.

Compared to the reference group, people who were inactive in both 1984-1986 and 2006-2008 had a 2-fold higher likelihood of all-cause death and 2.7-fold greater risk of dying from cardiovascular disease. Those with moderate activity at both time points had 60% and 90% raised risks of all-cause and cardiovascular deaths, respectively, compared to the reference group.

Dr Moholdt noted that there are clear recommendations about the amount of exercise adults should do to optimise their health, which are 150 minutes a week of moderate intensity or 75 minutes a week of vigorous intensity aerobic physical activity.

But she added: “An important point to make here is that physical activity levels even below the advised levels will give health benefits. Physical fitness is more important than the amount of exercise. Clinicians should individualise their advice and help people do even smaller amounts of activity that will improve fitness — this includes all types of exercise that make you breathe heavily.”

“Do activities you like and get more movement into your everyday life,” she continued. “For example, walk to the shops instead of driving, get off the metro a stop early, and use stairs instead of the lift. I recommend everyone to get out of breath at least a couple of times each week.”

As for those who changed categories between surveys, people who went from inactive to highly active had a mortality risk that was between those who were continually active or continually sedentary. In contrast, those who went from highly active to inactive had a similar risk of dying as those who were inactive at both surveys.

“Our data indicate that you can compensate for a previously inactive lifestyle and the sooner you get active, the sooner you will see positive results,” said Dr Moholdt. “My advice is to establish good exercise habits as early in life as possible. The health benefits extend beyond protection against premature death to effects in the body’s organs and on cognitive function. Physical activity helps us live longer and better lives.”

Share Button